Anonymous
Guest
Anonymous
Guest
I would say as an insider that folks that are leaving most were "poison" individuals that were there to collect $$$$$. Now that actual work is needed to be accomplished in order to launch next drug successfully, they are leaving. Definitely a changing of the guard here in which they seem to be bringing in younger, talented individuals that have potential to move the company forward. Just my two cents. It is a hectic environment for those that don't know what it is to actually make decisions and put in the effort.
Are you referring to the new drug coming out for HPP? It hasn't gotten approval yet, correct? How's the sales team for that division that was hired recently doing? I'm guessing they're working on patient identification. Are they having any luck? Very small market I believe, could be tough to identify.